Going by the mixed first-quarter print of NuVasive, Inc. (NASDAQ: NUVA), Canaccord Genuity believes any weakness presents a buying opportunity for the shares of the company.
Latest Ratings for NUVA
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2016 | Aegis Capital | Initiates Coverage On | Buy | |
| Oct 2016 | Barclays | Maintains | Overweight | |
| Jul 2016 | UBS | Maintains | Buy |
View More Analyst Ratings for NUVA
View the Latest Analyst Ratings
April 26, 2017 at 10:27PM
from Shanthi Rexaline
No comments:
Post a Comment